Expression of vascular endothelial growth factor in canine mammary tumors
Expression of vascular endothelial growth factor in canine mammary tumors
复制标题
DOI:
10.1354/vp.39-4-488
复制
发表时间:
2002-07-01
影响因子:
2.4
通讯作者:
De Vico, G
中科院分区:
文献类型:
--
作者:
Restucci, B;Papparella, S;De Vico, G
Vascular endothelial growth factor (VEGF) is a dimeric Protein that simulates angiogenesis in vitro and in vivo by inducing endothelial cell proliferation and migration. In this immunohistochemical study VEGF-immunolabeled cells were counted in a series of 10 benign and 40 malignant canine mammary, tumors, The morphologic pattern of VEGF positivity (intensity of immunolabeling and VEGF granule Si/C and distribution) was also evaluated. A low number of cells weakly positive for VEGF with few and small granules polarized to the luminal pole was detected in benign neoplasms. In contrast, in malignancies high number of VEGF-positive cells had strong immunolabeling, often with large granules found diffusely in the cytoplasm. This level of immunolabeling was more pronounced in the less differentiated, more malignant phenotypes (grade 3). Macrophages, which can synthesize VEGF, were strongly positive. Stromal and myoepithelial cells were negative. VEGF data were correlated statistically with intratumoral microvessel density (number of newly formed microvessels) and both measures were greater in less differentiated malignant neoplasms, demonstrating that angiogenesis and malignancy increase together. VEGF appears to be a powerful angiogenic factor in canine mammary tumors.